Kite Pharma Garners $250,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=36bd192c-023b-4c8c-8f7d-35ac280d4f97&Preview=1 - Date
12/14/2012 - Company Name
Kite Pharma - Mailing Address
10924 Le Conte Avenue Los Angeles, CA 90024 - Company Description
Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient’s own immune system to fight tumor cells. - Website
http://www.kitepharma.com - Transaction Type
Debt, Venture Equity - Transaction Amount
$250,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
